AU Stock MarketDetailed Quotes
IXC Invex Therapeutics Ltd
- 0.066
- -0.001-1.49%
20min DelayNot Open Dec 23 10:19 AET
4.96MMarket Cap-3.00P/E (Static)
0.066High0.066Low7.87KVolume0.066Open0.067Pre Close520.00Turnover0.10552wk High0.02%Turnover Ratio75.15MShares0.06052wk Low-0.022EPS TTM3.18MFloat Cap0.522Historical HighLossP/E (Static)48.16MShs Float0.038Historical Low-0.022EPS LYR0.00%Amplitude0.19Dividend TTM0.87P/B1Lot Size281.82%Div YieldTTM
About Invex Therapeutics Ltd Company
Invex Therapeutics Ltd is a biopharmaceutical company, focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised ICP including TBI, stroke and hydrocephalus. In addition, the Group has generated early-stage data on the use of Exenatide in the treatment of glaucoma, through the lowering of intraocular pressure in the eye. Geographically, it operates only in Australia.
Company Profile
SymbolIXC
Company NameInvex Therapeutics Ltd
Founded2019
MarketASX
Fiscal Year Ends06-30
Address38 Rowland Street Level 1
CitySubiaco
CountryAustralia
Zip Code6008
Phone+61 863820137
Share RegistryAUTOMIC REGISTRY SERVICES
LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
(08) 9324 2099
Company Executives
- Name
- Position
- Salary
- Thomas (Tom) Duthy
- Executive Director
- --
- David McAuliffe
- Non-Executive Director
- --
- David Colin Wheeler
- Non-Executive Director
- --
Heat List
AU
Overall
Symbol
Price
% Chg
No Data